Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis-Reference-Cited by-同舟云学术

Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis

Published:2023-01 Issue:1 Volume:28 Page:100762
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Muthiah Mark,Ng Cheng Han^ORCID,Chan Kai En,Fu Clarissa Elysia,Lim Wen Hui,Tan Darren Jun Hao,Nah Benjamin,Kong Gwyneth,Xiao Jieling,Yong Jie Ning,Tan Bryan,Syn Nicholas,Wang Jiong-Wei^ORCID,Sayed Nilofer,Tan Eunice,Chew Nicholas WS,Dan Yock Young^ORCID,Siddiqui Mohammad Shadab,Sanyal Arun J.,Noureddin Mazen

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference46 articles.

1. Nonalcoholic fatty liver disease 2020: the state of the disease;Cotter;Gastroenterology,2020

2. Global epidemiology of non-alcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD;Lim;Clin Gastroenterol Hepatol,2021

4. Comprehensive review and updates on holistic approach towards non-alcoholic fatty liver disease management with cardiovascular disease;Chew;Curr Atheroscler Rep,2022

5. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis;Tan;Lancet Oncol,2022

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the Crosstalk between Estrogen Deficiency and Gut-biota Dysbiosis in the Development of Diabetes Mellitus;Current Diabetes Reviews;2024-10

2. Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes: Risk of Heart Failure;2024-08-26

3. Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions;Nutrients;2024-07-11

4. Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD;Scientific Reports;2024-06-11

5. Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-06-01